Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79,218,487
-
Total 13F shares
-
69,288,382
-
Share change
-
-2,938,172
-
Total reported value
-
$121,236,834
-
Price per share
-
$1.75
-
Number of holders
-
76
-
Value change
-
-$8,133,770
-
Number of buys
-
39
-
Number of sells
-
31
Institutional Holders of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) as of Q4 2021
As of 31 Dec 2021,
Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
69,288,382 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., EcoR1 Capital, LLC, Bain Capital Life Sciences Investors, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, BOXER CAPITAL, LLC, Artal Group S.A., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and Alyeska Investment Group, L.P..
This page lists
76
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.